fa
Feedback
Synaptogenesis Pearls

Synaptogenesis Pearls

رفتن به کانال در Telegram
215
مشترکین
اطلاعاتی وجود ندارد24 ساعت
اطلاعاتی وجود ندارد7 روز
+1530 روز

در حال بارگیری داده...

ابر برچسب‌ها
هیچ داده‌ای
مشکلی وجود دارد؟ لطفاً صفحه را تازه کنید یا با مدیر پشتیبانی ما تماس بگیرید.
اشارات ورودی و خروجی
---
---
---
---
---
---
جذب مشترکین
سپتامبر '24
سپتامبر '24
+3
در 0 کانال‌ها
اوت '24
+240
در 1 کانال‌ها
Get PRO
ژوئیه '240
در 0 کانال‌ها
Get PRO
ژوئن '240
در 1 کانال‌ها
Get PRO
مه '240
در 2 کانال‌ها
Get PRO
آوریل '240
در 0 کانال‌ها
Get PRO
مارس '240
در 0 کانال‌ها
Get PRO
فوریه '24
+7
در 0 کانال‌ها
Get PRO
ژانویه '24
+9
در 0 کانال‌ها
Get PRO
دسامبر '23
+209
در 0 کانال‌ها
تاریخ
رشد مشترکین
اشارات
کانال‌ها
25 سپتامبر0
24 سپتامبر0
23 سپتامبر0
22 سپتامبر0
21 سپتامبر0
20 سپتامبر0
19 سپتامبر0
18 سپتامبر0
17 سپتامبر+1
16 سپتامبر0
15 سپتامبر0
14 سپتامبر0
13 سپتامبر0
12 سپتامبر0
11 سپتامبر+1
10 سپتامبر0
09 سپتامبر+1
08 سپتامبر0
07 سپتامبر0
06 سپتامبر0
05 سپتامبر0
04 سپتامبر0
03 سپتامبر0
02 سپتامبر0
01 سپتامبر0
پست‌های کانال
RBC disorders II Anemia: AMBOSSQs Pearls

2
Post-Partum Hemorrhage: AMBOSSQs Pearls
168
3
Case Files: Obstetrics; IUGR
Case Files: Obstetrics; IUGR
180
4
Case Files: Obstetrics; IUGR
Case Files: Obstetrics; IUGR
177
5
Case Files: Obstetrics ; Fetal Bradycardia
Case Files: Obstetrics ; Fetal Bradycardia
176
6
Obstetrics by Ten Teachers ll Eclampsia
Obstetrics by Ten Teachers ll Eclampsia
167
7
Approach to shoulder dystocia ll UpToDate
Approach to shoulder dystocia ll UpToDate
266
8
Normal labor and delivery: AMBOSSQs Pearls
192
9
Case Files: Obstetrics ; Diabetes in pregnancy
Case Files: Obstetrics ; Diabetes in pregnancy
230
10
Case Files: Obstetrics ; Diabetes in pregnancy
Case Files: Obstetrics ; Diabetes in pregnancy
212
11
Screening for sickle cell disease
Screening for sickle cell disease
260
12
Secondary Sjögren syndrome may develop in as many as 40%–65% of patients with primary biliary cirrhosis (PBC). Typical symptoms include dry mouth (xerostomia) and dry eyes (keratoconjunctivitis) and may precede PBC-related symptoms.
213
13
بدون متن...
190
14
In addition to its use in sickle cell anemia, Hydroxyurea is also used in the treatment of polycythemia vera and other myeloproliferative disorders. In these conditions, hydroxyurea is beneficial because of its myelosuppressive effects, which are a result of its inhibition of ribonucleoside diphosphate reductase. #Sickle_cell
184
15
بدون متن...
243
16
بدون متن...
188
17
https://youtu.be/8k0HZutTsP8?si=k4xoiGx4alSeGkbs
212
18
Anti hypertensive drug choice in ICH For most patients with an initial SBP ≥160 mmHg, we prefer nicardipine for initial treatment because it is fast-acting and can be quickly titrated. Blood pressure is monitored every five minutes and patients are monitored at least hourly to assess for neurologic deterioration. For most patients with an initial SBP <160 mmHg, we start with labetalol for its ease of administration and long duration of effect. 🚨🚨 Nitroprusside and nitroglycerin are typically avoided because they may increase intracranial pressure. UpToDate.
165
19
Reducing SBP below 130 mmHg in the first hours after ICH onset has not been shown clearly beneficial for reducing death or disability and may increase the risk of adverse events, including cerebral hypoperfusion and kidney injury. UpToDate.
115
20
Blood pressure management in ICH For patients with acute ICH who present with systolic blood pressure (SBP) between 150 and 220 mmHg, we suggest lowering of SBP to a target of 140 mmHg, ideally within the first one hour of presentation, provided the patient remains clinically stable. This degree of blood pressure reduction appears safe in most patients and may improve functional outcome. For patients with acute ICH who present with SBP >220 mmHg, we suggest rapid lowering of SBP to <220 mmHg. Thereafter, the blood pressure is gradually reduced (over a period of hours) to a target range of 140 to 160 mmHg, provided the patient remains clinically stable. Patients who deteriorate clinically during this period may require reduction of acute antihypertensive therapy. The optimal blood pressure goal is uncertain, but an SBP of 140 to 160 mmHg is a reasonable target for patients who remain clinically stable.
134